This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
8/3/2023
Operator
To all sites on hold, we do appreciate your patience and ask that you continue to stand by. With all sights on hold, we do appreciate your patience and ask that you continue to stand by.
Unknown
Thank you. Thank you.
Operator
Please stand by. Your program is about to begin. If you need assistance during your conference today, please press star zero. Good day, everyone, and welcome to the Sendak Second Quarter 2023 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Sharon Clary, Head of Investor Relations at Syndex Pharmaceuticals. Please go ahead.
You're reading a preview of the SNDX Q2 2023 earnings call.
Free account.
Disclaimer